Menu
Our mission is bold: extend human lifespan by decades and treat dozens of chronic diseases.
Nature has bestowed us with molecules that influence the aging process, which we boost with our AI platform to create powerful novel molecules targeting aging.
Current treatments for longevity are not safe, lack necessary technology, or are just for the rich. We are creating the first therapies to reach the world’s 8 billion people.
Introducing SenoSmart: Our platform uses 300,000 molecules, 949 gene mechanisms of action, 20 unique tissue types, and 15 meticulously chosen criteria predicting effectiveness, safety, metabolism, bioavailability, and clinical success.
With our platform, we have achieved >96% accuracy in identifying small molecules for our first target of aging: senescent cells.
Our first novel molecule lead from the SenoSmart platform has been shown to safely and effectively clear senescent cells and reverse a marker of kidney aging and disease.
© 2023 by ETTA Biotechnology in Palo Alto, CA